CLDICalidi Biotherapeutics, Inc.

NYSE www.calidibio.com


$ 1.15 $ 0.02 (1.32 %)    

Friday, 06-Sep-2024 15:59:21 EDT
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 1.155
$ 1.15 x 1,200
-- x --
-- - --
$ 1.01 - $ 90.00
76,388
na
9.34M
$ 0.21
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 03-15-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-21-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-31-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-10-2022 06-30-2022 10-Q
10 05-11-2022 03-31-2022 10-Q
11 03-30-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Calidi Biotherapeutics (AMEX:CLDI) reported quarterly losses of $(1.40) per share which beat the analyst consensus estimate of ...

Core News & Articles

Calidi Biotherapeutics, Inc. (NYSE:CLDI), a clinical-stage biotechnology company developing a new generation of targeted antitu...

Core News & Articles

Calidi Biotherapeutics, Inc. (NYSE:CLDI), a clinical-stage biotechnology company developing a new generation of targeted antitu...

Core News & Articles

https://ppubs.uspto.gov/pubwebapp/external.html?q=(12036278).pn

 why-calidi-biotherapeutics-cldi-shares-are-trading-lower

Calidi Biotherapeutics shares are trading lower by 14.3% during Monday's session. The company announced a 1-for-10 reverse ...

Core News & Articles

Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on Calidi Biotherapeutics (AMEX:CLDI) with a Buy rating and ann...

 why-calidi-biotherapeutics-is-moving-higher-monday

Calidi and SIGA are partnering in order to advance Calidi's RTNova virotherapy for lung cancer and metastatic solid tumors.

Core News & Articles

Calidi Biotherapeutics, Inc. (NYSE:CLDI), a clinical-stage biotechnology company developing a new generation of targeted antitu...

Core News & Articles

Calidi Biotherapeutics Inc. (NYSE:CLDI) ("Calidi"), a clinical-stage biotechnology company developing a new generation ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION